Legalization of Marijuana: Overview Law Research Starters
Expungements weren’t as automatic as originally envisioned, with some cases stalled on technical issues. The law allows adults 21 and over to possess up to two ounces of flower (permits the home cultivation of up to six plants), and automatically wipes the records of those convicted of low-level cannabis offenses. Making matters more difficult, medical patients are not permitted to grow at home.
The timing of data collection and the subsequent legalization of recreational cannabis in new states limited the study.19 A statistically significant correlation was observed in one study, indicating that individuals in legalized recreational cannabis states were more likely to transition to cannabis use when compared to both nonlegalized states , odds ratio OR 2.18, 95% CI 1.37–3.45, and states with only medical legalization (OR 1.73, 95% CI 1.23–2.42). The issue of legalizing recreational cannabis continues to be a contentious topic worldwide and throughout the United States.
Published in the British Journal of Addiction in December 2002 — a RAND study explored whether cannabis usage leads to subsequent use of cocaine and heroin. The study suggested that Connecticut should classify possession of one ounce or less of cannabis for adults aged 21 and older as a civil infraction. In 1997, the Connecticut Law Revision Commission analyzed states that had decriminalized cannabis, local access and global cannabis policy concluding that such decriminalization of small quantities had no impact on the later use of alcohol or more dangerous illicit drugs. Nevertheless, several studies have found no indication of a link between cannabis use and the later use of other illicit substances. It is not surprising that individuals who consume one of the least favored drugs often also partake in more widely used substances, including not only marijuana but also alcohol and tobacco. Key reasons for this substitution included ‘less withdrawal,’ ‘fewer side effects,’ and ‘improved symptom management.
Understanding Marijuana Legalization in a Minute
Then what they use it for is really all over the place—maybe because it makes them feel good (or because it helps them deal with certain symptoms), diseases, and disorders. It’s not like a medication you get prescribed for a very narrow symptom or a specific disease. Some want marijuana to be regulated like alcohol.
They reported that over 41 percent of the people said that they prefer to use marijuana instead of alcohol. A 2020 study by researchers at UCLA and Yale found that cannabis legalization had led to large amounts of new tax revenue and very little black market cannabis sales in states where the market was well-regulated, but large black markets and lack of tax revenue in states like California with poor regulation. In 2006 — a study by the University of California, Los Angeles found California has saved $2.50 for every dollar invested into Proposition 36, which decriminalized cannabis and other drug possession charges by allowing outpatient treatment programs instead of incarceration. That same study also indicated that the mountainous regions in Appalachia, and the rural areas of the West Coast are ideal for growing cannabis.
REPORTS ON THE INDUSTRY
There is concern that recreational cannabis legalization could lead to an increase in cannabis use disorder. Notable increases were seen in alcohol use disorder (OR 2.7 — 95% CI 1.9–3.8), nicotine dependence (OR 1.7, 95% CI 1.2–2.4), and other substance use disorders (OR 2.6, 95% CI 1.6–4.4). The strengths of these associations are unclear (and the causal link between cannabis use and these disorders has yet to be fully established), highlighting the need for more rigorous studies. Nearly half of regular users—defined as weekly or more frequent use35—experience withdrawal symptoms when cannabis is abruptly discontinued.28 These symptoms can include dysphoria, nausea, abdominal pain, tremors, sweating, fever, chills, and headaches.31,36,37 Whereas blood alcohol concentration can be used to determine acute alcohol intoxication, cannabis presents difficulties due to its high lipophilicity and pharmacokinetic properties.28 For instance, urine drug screens commonly used in emergency departments may report positive tetrahydrocannabinol results up to 30 days after consumption.29 Although negative effects on coordination and reflexes can be observed at the roadside — there is currently a lack of standardized measurement tools to accurately assess acute cannabis impairment. While cannabis use may influence driving abilities, the seemingly contradictory study findings suggest that the overall impact of cannabis legalization on traffic safety requires further investigation to clarify the association between patterns of cannabis use and traffic safety outcomes.
What won’t change with marijuana’s rescheduling?
Understanding the difference matters if you want to stay out of trouble. In this guide, we’re going to break it all down in plain language, so you know exactly what you can and can’t do, no matter where you are. Several studies have found no increase in teen use in states that have legalized cannabis for medical purposes.
Does this rescheduling legalize marijuana under federal law?
The new order clearly states that researchers studying sanctioned medical marijuana products will not be in violation of federal law. The reclassification (which follows a 2022 law that sought to reduce scientists’ administrative burdens), could further reduce red tape for researchers trying to study marijuana. When Congress finally takes a meaningful swing—be it SAFE Banking (FDCA reform), or full descheduling—operators who prepared today will capture tomorrow’s upside. Banking Marginally easier for national banks wary of “proceeds of criminal activity.” FinCEN guidance unchanged; SAFE Banking Act still needed. Unlike alcohol (THC can remain detectable in the body long after its impairing effects have worn off), making it challenging to establish clear legal standards for impaired driving.
U.S. Vape Market Report: Free Download
Consequently — many studies on the therapeutic benefits of cannabis were either denied or altered to comply with the limited scope and mission of NIDA. Further research is needed to explore the impact of recreational cannabis legalization on adverse cannabis-drug interaction rates. However, the pathophysiology behind cannabis use disorder remains unclear, as there is insufficient evidence to support the notion that striatal dopamine receptors, which are involved in alcohol or opioid abuse disorders, also modulate cannabis use disorder.37
This may influence studies comparing states with and without legalized recreational cannabis because the increase in reported use may skew results. Self-reported cannabis use may increase in the context of recreational cannabis legalization due to a lower perceived risk, social desirability bias, and a diminished fear of criminal penalties. It is important to recognize that most epidemiologic studies on substance use rely on self-reported data, which can underestimate actual rates of use.14 Survey data are prone to recall and social desirability biases, leading to underreporting or misrepresentation of substance use.
In December 2006 — a 12-year gateway drug hypothesis study on 214 boys from ages 10–12 by the American Psychiatric Association was published in the American Journal of Psychiatry. Paul Armentano, policy analyst for NORML, claimed because the rats were given THC at the young age of 28 days, it is impossible to extrapolate the results of this study to humans. The rats were allowed to administer heroin by pushing a lever and the study found the rats given THC took larger doses of heroin. The study gave six of the twelve “teenage” rats a small dose of THC, reportedly equivalent to one joint smoked by a human, every three days. The study also found the mean age at onset of cannabis use and the mean age of cannabis users are both higher in Amsterdam than in San Francisco. The study found no evidence that the decriminalization of cannabis leads to subsequent use of other illicit drugs.
